Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 42OTHER_GOV 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 2Radiation Injuries 1Psoriasis Vulgaris 1Pelvic Inflammatory Disease 1Neoplasms 1Inflammation 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Probiotics × Clear all
NCT03994055 2025-05-25

Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer

National Institute of Cancerología

Phase NA Completed
136 enrolled
Gynecologic

Pelvic Inflammatory Disease, Uterine Cervical Neoplasms, Neoplasms, Radiation Injuries

NCT05736315 2023-02-21

Use of a Fermented Dairy Beverage in Cervical Cancer Patients Undergoing Concurrent Chemoradiation Therapy

National Institute of Cancerología

Phase NA Completed
42 enrolled
Gynecologic

Uterine Cervical Neoplasms, Inflammation

NCT05254249 2022-02-24

Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris

Dr. Soetomo General Hospital

Phase 1/2 Unknown
75 enrolled

Psoriasis Vulgaris

Data powered by HemOnc (CC BY 4.0) Colophon ⚡